SecSonar.com

SI-BONE, Inc. (SIBN)

SI-BONE, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

SI-BONE, Inc. (SIBN) is a Medical - Devices company based in US with a market capitalization of $631.8M. Revenue grew 20.2% year-over-year and free cash flow was negative at -$9.1M. This page tracks SIBN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 349 employees · IPO Oct 17, 2018

Valuation

Valuation & price

$14.16 · as of May 17, 2026 · -33.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.56

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.88$16.57$12.27Jul 25Dec 25Jul 26Jul 7, 25$18.02Jul 9, 25$18.44Jul 11, 25$17.20Jul 15, 25$16.92Jul 17, 25$16.73Jul 21, 25$16.67Jul 23, 25$17.76Jul 25, 25$17.25Jul 29, 25$17.82Jul 31, 25$17.03Aug 4, 25$17.90Aug 6, 25$16.41Aug 11, 25$15.40Aug 13, 25$15.70Aug 15, 25$15.46Aug 19, 25$15.49Aug 21, 25$15.64Aug 25, 25$16.05Aug 27, 25$16.59Aug 29, 25$16.67Sep 3, 25$16.22Sep 5, 25$16.29Sep 9, 25$16.04Sep 11, 25$16.32Sep 16, 25$15.10Sep 18, 25$15.18Sep 22, 25$14.84Sep 24, 25$14.22Sep 26, 25$14.05Sep 30, 25$14.72Oct 2, 25$14.31Oct 6, 25$14.49Oct 8, 25$15.21Oct 10, 25$14.78Oct 14, 25$15.26Oct 16, 25$15.10Oct 21, 25$15.52Oct 23, 25$15.43Oct 27, 25$15.66Oct 29, 25$15.26Oct 31, 25$14.83Nov 4, 25$15.35Nov 6, 25$15.19Nov 10, 25$15.68Nov 12, 25$18.00Nov 14, 25$17.42Nov 18, 25$18.36Nov 20, 25$18.68Nov 25, 25$19.67Nov 28, 25$19.46Dec 2, 25$19.42Dec 4, 25$19.24Dec 8, 25$19.00Dec 10, 25$18.79Dec 12, 25$18.59Dec 16, 25$19.42Dec 18, 25$20.25Dec 22, 25$20.81Dec 24, 25$20.36Dec 29, 25$20.17Jan 2, 26$19.79Jan 6, 26$20.40Jan 8, 26$20.88Jan 12, 26$17.87Jan 14, 26$17.44Jan 16, 26$17.00Jan 21, 26$16.98Jan 23, 26$16.80Jan 27, 26$17.03Jan 29, 26$16.55Feb 2, 26$16.37Feb 4, 26$15.83Feb 9, 26$15.39Feb 11, 26$15.24Feb 13, 26$15.33Feb 18, 26$15.74Feb 20, 26$15.48Feb 24, 26$15.29Feb 26, 26$16.23Mar 2, 26$15.70Mar 4, 26$14.71Mar 6, 26$13.83Mar 10, 26$13.82Mar 12, 26$13.82Mar 17, 26$12.84Mar 19, 26$12.77Mar 23, 26$12.99Mar 25, 26$12.91Mar 27, 26$12.29Mar 31, 26$12.63Apr 2, 26$13.12Apr 7, 26$13.17Apr 9, 26$13.69Apr 13, 26$14.00Apr 15, 26$14.49Apr 17, 26$14.09Apr 22, 26$13.87Apr 24, 26$13.52Apr 28, 26$12.36Apr 30, 26$12.39May 4, 26$13.35May 6, 26$12.99May 8, 26$12.27May 12, 26$13.90May 14, 26$14.60May 18, 26$14.76May 20, 26$14.82May 22, 26$14.68May 28, 26$14.41Jun 1, 26$13.87Jun 3, 26$13.92Jun 5, 26$15.12Jun 9, 26$15.53Jun 11, 26$15.14Jun 15, 26$15.12Jun 17, 26$15.21Jun 22, 26$15.82Jun 24, 26$16.34Jun 26, 26$17.33Jul 2, 26$17.11
$11.6152-week range$21.40
Loading valuation history…

Fundamentals

Key fundamentals

$631.8M

Market cap

20.2%

Revenue growth (YoY)

79.6%

Gross margin

-$9.1M

Free cash flow (USD)

-$146.7M

Net debt

Net cash position

4.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$42.1MFY 2017$48.0MFY 2018$55.4MFY 2019$67.3MFY 2020$73.4MFY 2021$90.2MFY 2022$106.4MFY 2023$138.9MFY 2024$167.2MFY 2025$200.9M
$42.1M$200.9M

Free cash flow by year

2016 → 2025

FY 2016$-17.2MFY 2017$-18.0MFY 2018$-15.5MFY 2019$-34.1MFY 2020$-33.2MFY 2021$-45.9MFY 2022$-51.2MFY 2023$-26.5MFY 2024$-22.9MFY 2025$-9.1M
-$17.2M-$9.1M

Gross margin by year

2021 → 2025

FY 202188.4%FY 202285.2%FY 202378.8%FY 202479.0%FY 202579.6%
88.4%79.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $55KDUNN JEFFREY W · Director · $54.5KJun 8, 2026Filing
  • 8-K eventLease AmendmentJun 8, 2026Filing
  • Insider sellInsider Sell $104KDavis Timothy E JR · Director · $104.2KJun 1, 2026Filing
  • Insider sellInsider Sell $69KMaheshwari Anshul · Chief Financial Officer · $68.5KMay 20, 2026Filing
  • Insider sellInsider Sell $55KPISETSKY MICHAEL A. · SVP, Ops & Adm/Chief Legal Ofr · $54.5KMay 20, 2026Filing
  • Insider sellInsider Sell $220KFRANCIS LAURA · Director, Chief Executive Officer · $220KMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing
  • Insider sellInsider Sell $4KDUNN JEFFREY W · Director · $4.4KMay 5, 2026Filing
  • Insider sellInsider Sell $40KPISETSKY MICHAEL A. · SVP, Ops & Adm/Chief Legal Ofr · $40.5KApr 3, 2026Filing

Questions

Frequently asked questions

What is SI-BONE, Inc.'s market cap?

SI-BONE, Inc. (SIBN) has a market capitalization of $631.8M.

What is SIBN's P/E ratio?

A meaningful P/E ratio is not available for SIBN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SIBN's price-to-book (P/B) ratio?

SIBN trades at 3.56 times book value per share.

Are insiders buying SIBN stock?

SEC Form 4 filings show no open-market insider buys at SI-BONE, Inc. in the last 90 days (6 sells).

Same arena

Related companies in Medical - Devices

BWAY

BrainsWay Ltd.

$613.4M

CERS

Cerus Corporation

$612.8M

NPCE

NeuroPace, Inc.

$590.8M

BVS

Bioventus Inc.

$580.6M

CBLL

CeriBell, Inc.

$703M

TCMD

Tactile Systems Technology, Inc.

$560.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.